Price
Frequently asked questions
What is Boston's market capitalization?
What is Boston's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Boston?
What are the analyst ratings and target price for Boston's stock?
What is Boston's revenue over the trailing twelve months?
What is the EBITDA for Boston?
What is the free cash flow of Boston?
What is the 5-year beta of Boston's stock?
How many employees does Boston have, and what sector and industry does it belong to?
What is the free float of Boston's shares?
Financials
Market Cap
$130.76B5Y beta
0.80EPS (TTM)
$1.21Free Float
1.47BP/E ratio (TTM)
73.34Revenue (TTM)
$15.91BEBITDA (TTM)
$4.63BFree Cashflow (TTM)
$2.16BPricing
Analyst Ratings
The price target is $82.92 and the stock is covered by 31 analysts.
Buy
28
Hold
3
Sell
0
Information
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.
48,000
Medical Equipment & Supplies
Health Care
Identifier
ISIN
Primary Ticker